X07876-03
|
97.2
|
wingless-type MMTV integration site family member 2
|
L31951-03
|
94.1
|
mitogen-activated protein kinase 9
|
U29343-04
|
74.6
|
hyaluronan-mediated motility receptor (RHAMM)
|
U09304-01
|
63.3
|
ephrin-B1
|
U43746-02
|
62.6
|
breast cancer 2, early onset
|
X63629-03
|
57.8
|
cadherin 3, type 1, P-cadherin (placental)
|
M25753-01
|
54.5
|
cyclin B1
|
U69611-04
|
50.7
|
a disintegrin and metalloproteinase domain 17 (tumor necrosis factor, alpha, converting enzyme)
|
M63167-01
|
47.9
|
v-akt murine thymoma viral oncogene homolog 1
|
M77830-02
|
43.9
|
desmoplakin (DPI, DPII)
|
M29366-04
|
40.9
|
v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian)
|
M15990-01
|
39.3
|
v-yes-1 Yamaguchi sarcoma viral oncogene homolog 1
|
X53586-04
|
38.4
|
integrin, alpha 6
|
U43746-15
|
37.1
|
breast cancer 2, early onset
|
J04088-07
|
36.5
|
topoisomerase (DNA) II alpha (170 kD)
|
X87852-02
|
36.5
|
plexin A3
|
X05232-03
|
32.7
|
matrix metalloproteinase 3 (stromelysin 1, progelatinase)
|
M29039-02
|
32.7
|
jun B proto-oncogene
|
X80343-01
|
32.4
|
cyclin-dependent kinase 5, regulatory subunit 1 (p35)
|
L34058-01
|
30.3
|
cadherin 13, H-cadherin (heart)
|
Y10479-01
|
30.3
|
E2F transcription factor 3
|
M14505-02
|
29.7
|
cyclin-dependent kinase 4
|
J02958-06
|
29.7
|
met proto-oncogene (hepatocyte growth factor receptor)
|
U43746-11
|
29.1
|
breast cancer 2, early onset
|
U58334-01
|
29.1
|
tumor protein p53 binding protein, 2
|
X63629-01
|
28.5
|
cadherin 3, type 1, P-cadherin (placental)
|
U58334-02
|
28.2
|
tumor protein p53 binding protein, 2
|
X56654-01
|
27.9
|
desmoglein 1
|
M81934-01
|
27.6
|
cell division cycle 25B
|
X66363-03
|
27.6
|
PCTAIRE protein kinase 1
|
M26880-04
|
26.8
|
ubiquitin C
|
U37139-02
|
25.6
|
integrin beta 3 binding protein (beta3-endonexin)
|
L29222-02
|
24.2
|
CDC-like kinase 1
|
U01038-02
|
21.9
|
polo-like kinase (Drosophila)
|
M35410-02
|
21.1
|
insulin-like growth factor binding protein 2 (36 kD)
|
M35296-07
|
18.9
|
v-abl Abelson murine leukemia viral oncogene homolog 2 (arg, Abelson-related gene)
|
AF022385-02
|
18.6
|
programmed cell death 10
|
M30704-01
|
17.5
|
amphiregulin (schwannoma-derived growth factor)
|
U43142-01
|
16.1
|
vascular endothelial growth factor C
|
M32315-05
|
15.9
|
tumor necrosis factor receptor superfamily, member 1B
|
M85289-12
|
15.9
|
heparan sulfate proteoglycan 2 (perlecan)
|
AB000220-03
|
13.5
|
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3C
|
U29343-01
|
11.2
|
hyaluronan-mediated motility receptor (RHAMM)
|
NM_005417-02
|
10.7
|
v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)
|
U16752-04
|
70.2
|
stromal cell-derived factor 1
|
D21337-07
|
35.2
|
collagen, type IV, alpha 6
|
Y00815-03
|
16.9
|
protein tyrosine phosphatase, receptor type, F
|
X04571-05
|
13.8
|
epidermal growth factor (beta-urogastrone)
|
L12002-06
|
10.9
|
integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor)
|